Published Paper Details:

In many populations, multivitamin/mineral supplements (MVM) are commonly used. MVM is specifically advised for pregnant women to improve the outcome of birth, lower low birth weight and miscarriage rates, and to supplement iron and folic acid. However, the general population frequently uses MVM. This raises questions regarding the safety of using these supplements over an extended period of time. We searched the literature for randomised, controlled studies on dietary supplements containing at least nine vitamins and three minerals with a maximum concentration of 100% of the recommended dietary allowance to determine the safety of MVM use. We discovered nine papers analysing the usage and effectiveness of MVM in healthy people and pregnant women, as well as six studies in the elderly where side effects were observed. The prevalence of cancer is steadily rising and is quickly spreading around the world. Doxorubicin HCl was the first liposomal-encapsulated anticancer medication to earn clinical approval against cancers such as solid tumours, transplantable leukaemias, and lymphomas. The goal of this article is to give a general overview of doxorubicin's role in cancer treatment. The doxorubicin- containing liposome in pegylated liposomal doxorubicin has a coating of polyethylene glycol (PEG) due to the pegylation procedure. To address the issues with earlier formulations, non- pegylated liposomal doxorubicin (NPLD) was created. With its innovative drug delivery technology, Nudoxa (NPLD) offers the advantage of pegylated liposomal doxorubicin without the main adverse effect of hand foot syndrome.